Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings

Shares (Q2 2026)
4,073,787
Value
$98.8M
% of portfolio
6.6%
Quarters held
22
Since Q1 2021
Holdings of NRIX by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,073,787$98.8M6.6%−3,659,021−47.3%ReducedHolders
Q1 20267,732,808$119.9M7.9%−361,100−4.5%ReducedHolders
Q4 20258,093,908$153.5M11.3%+4,415,514+120.0%AddedHolders
Q3 20253,678,394$34.0M3.3%−54,494−1.5%ReducedHolders
Q2 20253,732,888$42.5M4.5%−319,039−7.9%ReducedHolders
Q1 20254,051,927$48.1M4.5%−140,700−3.4%ReducedHolders
Q4 20244,192,627$79.0M5.5%−88,354−2.1%ReducedHolders
Q3 20244,280,981$96.2M5.7%−142,635−3.2%ReducedHolders
Q2 20244,423,616$92.3M5.6%−59,400−1.3%ReducedHolders
Q1 20244,483,016$65.9M2.4%+1,226,497+37.7%AddedHolders
Q4 20233,256,519$33.6M1.2%+407,692+14.3%AddedHolders
Q3 20232,848,827$22.4M1.1%−8,482−0.3%ReducedHolders
Q2 20232,857,309$28.5M1.1%+107,925+3.9%AddedHolders
Q1 20232,749,384$24.4M1.1%−251,400−8.4%ReducedHolders
Q4 20223,000,784$32.9M1.3%−5,900−0.2%ReducedHolders
Q3 20223,006,684$39.2M1.5%00.0%UnchangedHolders
Q2 20223,006,684$38.1M1.5%−12,100−0.4%ReducedHolders
Q1 20223,018,784$42.3M1.3%+60,500+2.0%AddedHolders
Q4 20212,958,284$85.6M1.9%−134,793−4.4%ReducedHolders
Q3 20213,093,077$92.7M1.6%−97,000−3.0%ReducedHolders
Q2 20213,190,077$84.6M1.3%−124,040−3.7%ReducedHolders
Q1 20213,314,117$103.0M1.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.